|
ADAL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6827999993474E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.03740000320951E-08 |
| Normal-vs-Stage2 |
4.29889999997712E-06 |
| Normal-vs-Stage3 |
2.08390005251857E-09 |
| Normal-vs-Stage4 |
3.55160000000687E-05 |
| Stage1-vs-Stage2 |
5.438000E-01 |
| Stage1-vs-Stage3 |
1.327980E-02 |
| Stage1-vs-Stage4 |
4.915200E-01 |
| Stage2-vs-Stage3 |
1.921800E-01 |
| Stage2-vs-Stage4 |
8.318800E-01 |
| Stage3-vs-Stage4 |
3.647200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.81319999809682E-08 |
| Normal-vs-AfricanAmerican |
9.03721542044877E-13 |
| Normal-vs-Asian |
1.74470999999565E-05 |
| Caucasian-vs-AfricanAmerican |
7.205900E-04 |
| Caucasian-vs-Asian |
1.262180E-01 |
| AfricanAmerican-vs-Asian |
4.439800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02020003556191E-09 |
| Normal-vs-Female |
1.03819999996979E-06 |
| Male-vs-Female |
6.079800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.18689988129972E-10 |
| Normal-vs-Extreme_Weight |
2.08020000114217E-08 |
| Normal-vs-Obese |
2.13370000001767E-06 |
| Normal-vs-Extreme_Obese |
2.691700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.089200E-01 |
| Normal_Weight-vs-Obese |
2.598400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.330300E-02 |
| Extreme_Weight-vs-Obese |
8.864600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.618410E-01 |
| Obese-vs-Extreme_Obese |
3.568600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.60230000273631E-08 |
| Normal-vs-Age(41-60Yrs) |
1.13669999968202E-07 |
| Normal-vs-Age(61-80Yrs) |
3.02379999927993E-08 |
| Normal-vs-Age(81-100Yrs) |
2.45740000004435E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.260300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.067600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.958000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.733600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.781840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.509200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.60409999949707E-07 |
| Normal-VS-Type2 PRCC |
3.57079998902776E-09 |
| Normal-VS-KIRP CIMP |
1.59540000099767E-08 |
| Normal-VS-Unclassified PRCC |
1.957960E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.121900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.275300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.410000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.426460E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.365960E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.580700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.96140001410095E-09 |
| Normal-vs-N1 |
3.0980773502165E-12 |
| Normal-vs-N2 |
3.763300E-04 |
| N0-vs-N1 |
9.003100E-03 |
| N0-vs-N2 |
3.123800E-01 |
| N1-vs-N2 |
8.211400E-01 |
|
|
